The pharmaceuticals and drug company, Cipla informed the exchanges on Thursday that it has launched Daptomycin for Injection, 500mg/vial, single-dose vial for intravenous use only.

The second project is a mega contract for Electrical and C&I Maintenance at NTPC Khargone (2x660 MW) for a total contract price of approximately Rs. 13 crore, for a period of 36 months.

The project work as stated by the company includes excavation of overburden of first dig for composite work consisting of blast hole drilling, loading and transportation of broken rocks and soil etc.

Hinduja Global Solutions (HGS) has bagged a new contract order award with the Disclosure and Barring Service (DBS). DBS helps employers make safer recruitment decisions each year by processing and issuing DBS checks required by those working with children and vulnerable adults.

Following stocks are close to their 52-weeks low as at 13:07 p.m. on September 26, 2019.

The markets on September 26, 2019 opened gap down. BSE Sensex is trading at 38,891.83, up by 298.31 points and the Nifty is trading at 11,540.50, up by 100.30 points.

AstraZeneca Pharma India has received import and market permission in Form 45 (Marketing Authorization) from the Drugs Controller General of India.

NHPC Limited has signed a Memorandum of Understanding (MoU) with Government of Himachal Pradesh for execution of 449 MW Dugar HE Project located in Chamba District, Himachal Pradesh.

Overall volumes in futures & options currently stand at 2,30,48,515 contracts with a turnover of Rs. 15,70,828.38 crore.

Overall volumes in futures & options currently stand at 2,30,48,515 contracts with a turnover of Rs. 15,70,828.38 crore.